A first of it’s kind digital therapy for major depressive disorder opens up opportunities for market growth.
The U.S. Food and Drug Administration (FDA) has cleared the first prescription digital therapeutic authorized for the adjunctive treatment of major depressive disorder (MDD) symptoms.
This will help the entire industry understand the base level requirements to obtain FDA approval for a digital health depression treatments.
There will still be big barriers to overcome, including the fact that this is a prescription only product, with no reimbursement opportunity, and can only be used in conjunction with a antidepressant medication.
So, no real improvement for accessibility and affordability of care, but… this is how markets develop in the medical space: one step at a time (and this is a big step).
My prediction? Some day these solutions will be available without a prescription, covered by insurance, and will replace or reduce medications💊… AND they will be games, because when compared to this study conducted on Mario Odyssey, this newly approved DTx may not be nearly as effective!!!
Mario Study:Â https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2023.1173652/full
Source: https://medicalxpress.com/news/2024-04-fda-prescription-digital-therapy-major.amp
